Comparison Between Adalimumab and Infliximab in Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis

Background and Aims: Anti–tumor necrosis factor therapy has been a mainstay of medical management of perianal Crohn’s disease (CD). This systematic review and meta-analysis aimed to compare the efficacy of adalimumab (ADA) and infliximab (IFX) for the treatment of perianal fistulizing CD. Methods: W...

Full description

Bibliographic Details

Published in:	Gastro Hep Advances
Main Authors:	Tarek Aboursheid, Azizullah Beran, Mohamad Hijazi, Mhd Kutaiba Albuni, Bisher Sawaf, John J. Guardiola, Khaled Abdeljawad, Benjamin D. McDonald, David T. Rubin
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Subjects:	Adalimumab Infliximab Perianal Crohn’s disease Anti-TNF Fistula
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772572325000846